Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
The medical management of many diseases and conditions can include either restriction or provision of specific essential nutrients. When such nutrients are needed, there are often both prescription and nonprescription products available, as in the case of nicotinic acid or omega-3 fatty acids. Although they may seem to contain similar ingredients, there may be important differences between the prescription and dietary-supplement preparations. The manufacturing of prescription pharmaceutical products is regulated by the US Food and Drug Administration (FDA), which mandates standards for consistency and quality assurance. Dietary supplements are available to consumers under the provisions of the Dietary Supplement Health and Education Act of 1994, for which the FDA has the burden of proving a dietary supplement is harmful rather than requiring the manufacturer prove that the supplement is safe. Consumers and medical professionals should be aware of the important qualitative and quantitative differences between the FDA-approved prescription formulations and dietary supplements, particularly when an essential nutrient is part of the medical management of a disease or condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to fish oils and other OM-3 dietary supplements, Rx OM-3s are highly purified (Fig. 3) [8, 19, 60] and required to meet strict FDA regulatory standards [17, 47].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [47]
Citations
Cites
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Self-citationEffects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 1×
“One study, the diet and reinfarction trial (DART), showed that subjects advised to eat fatty fish had a 29% reduction in 2-year all-cause mortality compared with subjects not given dietary advice [27].”
BackgroundMeta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Research works printed but not linked: 7
- 2005, Vitamin Supplements., 1213, 57
- 2004, FDA Announces Qualified Health Claims for Omega-3 Fatty Acids., 1
- 1989, Lancet, 2, 757
- 2003, Cardiovasc Rev Rep, 24, 520
- 2005, US Pharmacist, 30, 61
- 1994, Eur J Clin Nutr, 48, 859
- 2006, Med Lett Drugs Ther, 48, 59
Cited by
Wang, H., Oo Khor, T., Shu, L., Su, Z.-Y., Fuentes, F., Lee, J.-H., & Tony Kong, A.-N. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833026 · Cited by 529
“Collins and colleagues reviewed the clinically relevant differences between dietary supplement and prescription formulations of omega-3 fatty acids in the context of legislative and regulatory issues [324].”
Bays, H. E., Tighe, A. P., Sadovsky, R., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 265
Self-citationImpact of omega-3 fatty acids in Parkinson's disease
Bousquet, M., Calon, F., & Cicchetti, F. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.001 · Cited by 135
Overview of omega-3 Fatty Acid therapies.
Bradberry, J. C., & Hilleman, D. E. (2013) · PubMed Central · Cited by 181
The modification of plant oil composition via metabolic engineering—better nutrition by design
Haslam, R. P., Ruiz‐Lopez, N., Eastmond, P., Moloney, M., Sayanova, O., & Napier, J. A. (2013) · Plant Biotechnology Journal · doi:10.1111/pbi.12012 · Cited by 100
“Even against these rather modest levels, adult consumption in the UK is on average half that figure (Givens and Gibbs, 2008) yet there is a growing gulf in what we have available in the oceans, and what we need to consume for a healthier human diet (Collins et al., 2008)—currently, the planet is producing around 1 mil…”
Background
Metadata
- Authors
- Collins, N., Tighe, A. P., Brunton, S. A., & Kris-Etherton, P. M.
- Affiliations
- Cabarrus College of Health Sciences (US)
- ORCID
- Brunton, Stephen A.
- Venue
- Journal of the American College of Nutrition
- Publisher
- Informa UK Limited
- Published
- 2008-12
- Volume
- 27
- Issue
- 6
- Pages
- 659-666
- ISSN
- 0731-5724 (ISSN-L)
- 1541-1087
- OpenAlex
- W2043152421
- Cited by
- 44
- References
- 41
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 1 · 2016: 2 · 2015: 1 · 2014: 6 · 2013: 6 · 2012: 4
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American College of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
- Keywords
- omega-3 fatty acids, dietary supplements, prescription drugs, FDA regulation, Dietary Supplement Health and Education Act of 1994, essential nutrients, nicotinic acid, quality assurance, regulatory burden
- MeSH terms
- Hypolipidemic Agents, Pharmaceutical Preparations, Nonprescription Drugs, Humans, Legislation, Drug, Legislation, Food, United States, United States Food and Drug Administration, Hypertriglyceridemia, Fatty Acids, Omega-3, Dietary Supplements, Prescription Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective. https://app.cochat.ai/papers/10.1080/07315724.2008.10719743
- The paper
- Collins, N., Tighe, A. P., Brunton, S. A., & Kris-Etherton, P. M. (2008). Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective. Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2008.10719743
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.